Back

Agent-based modeling and phylogenetic analysis suggests that COVID-19 will remain a low-severity albeit highly transmissible disease

Toledo-Roy, J. C.; Garcia, G. E.; Valdes, A. M.; Frank, A.

2023-01-28 epidemiology
10.1101/2023.01.27.23285126 medRxiv
Show abstract

The ongoing COVID-19 pandemic is still producing hundreds of thousands of cases worldwide. However, the currently dominant Omicron variant (and its sub-variants) have proven to be less virulent than previous dominant variants, resulting in proportionately fewer severe cases, hospitalizations and deaths. Nonetheless, a persistent concern is that new mutations of the SARS-CoV-2 virus may yet produce more virulent variants. In the present study we provide evidence supporting the hypothesis that this is unlikely, and that COVID-19 will remain a low-severity although highly transmissible disease. Three complementary pieces of evidence support our argument. First, empirical observations suggest that the transmission advantage that Omicron (sub)variants enjoy is in large part due to their cell tropism in the upper respiratory tract, which renders them less virulent. Second, when a negative link between transmissibility and virulence is included in agent-based epidemiological models, viruses evolve towards lower virulence. Third, genetic diversification of SARS-CoV-2 suggests that epistasis in the Omicron family reduces the diversity of successful variants. Taken together these observations point to a high likelihood that the severity of COVID-19 will remain sufficiently low for an endemic status to be reached, provided that vaccination campaigns and sensible hygiene and social measures continue worldwide, as suggested by the World Health Organization.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
PLOS Computational Biology
1863 papers in training set
Top 2%
12.6%
2
Viruses
332 papers in training set
Top 0.2%
11.0%
3
Evolution, Medicine, and Public Health
14 papers in training set
Top 0.1%
9.7%
4
Virus Evolution
155 papers in training set
Top 0.3%
7.8%
5
Journal of The Royal Society Interface
235 papers in training set
Top 1%
4.0%
6
Epidemics
116 papers in training set
Top 0.6%
4.0%
7
Proceedings of the Royal Society B: Biological Sciences
393 papers in training set
Top 2%
3.2%
50% of probability mass above
8
Philosophical Transactions of the Royal Society B
51 papers in training set
Top 0.2%
2.8%
9
Nature Communications
5641 papers in training set
Top 38%
2.8%
10
PLOS Biology
486 papers in training set
Top 2%
2.6%
11
PLOS Pathogens
820 papers in training set
Top 5%
2.6%
12
Scientific Reports
3612 papers in training set
Top 44%
2.4%
13
PLOS ONE
5266 papers in training set
Top 43%
2.4%
14
Royal Society Open Science
214 papers in training set
Top 3%
2.1%
15
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 26%
1.9%
16
Clinical Infectious Diseases
235 papers in training set
Top 2%
1.7%
17
Molecular Biology and Evolution
542 papers in training set
Top 3%
1.7%
18
eLife
5828 papers in training set
Top 52%
1.5%
19
Vaccines
198 papers in training set
Top 2%
1.3%
20
COVID
14 papers in training set
Top 0.2%
1.3%
21
Philosophical Transactions of the Royal Society B: Biological Sciences
72 papers in training set
Top 1%
1.1%
22
The Journal of Infectious Diseases
202 papers in training set
Top 3%
1.1%
23
Epidemiology and Infection
89 papers in training set
Top 2%
1.1%
24
BMC Medicine
176 papers in training set
Top 4%
1.0%
25
Pathogens
56 papers in training set
Top 1%
1.0%
26
PLOS Genetics
862 papers in training set
Top 11%
1.0%
27
Science Advances
1243 papers in training set
Top 30%
0.8%
28
Journal of Clinical Medicine
97 papers in training set
Top 5%
0.8%
29
iScience
1154 papers in training set
Top 35%
0.8%
30
Eurosurveillance
83 papers in training set
Top 1%
0.6%